← Back to Analyst Consensus 
KRRO Buy
Korro Bio, Inc.
Current Price —
Implied Upside —
Analysts 18
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 18, 2026 (23 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 6, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 20, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| May 19, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 18, 2026 | Citigroup | initiate | — → Buy | — | 54% |
| Mar 13, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| Mar 13, 2026 | Raymond James | upgrade | Market Perform → Outperform | — | 54% |
| Feb 19, 2026 | Clear Street | upgrade | Hold → Buy | $18 | 49% |
| Feb 17, 2026 | William Blair | upgrade | Market Perform → Outperform | $0 | 48% |
| Jan 29, 2026 | Chardan Capital | upgrade | Neutral → Buy | $15 | 47% |
| Jan 29, 2026 | HC Wainwright & Co. | upgrade | Neutral → Buy | $20 | 44% |
| Jan 29, 2026 | Piper Sandler | upgrade | Neutral → Overweight | $30 | 54% |
| Jan 28, 2026 | Oppenheimer | upgrade | Perform → Outperform | $22 | 52% |
| Jan 28, 2026 | Cantor Fitzgerald | upgrade | Neutral → Overweight | $21 | 50% |
| Nov 14, 2025 | Jones Trading | downgrade | Buy → Hold | $0 | 50% |
| Nov 13, 2025 | William Blair | downgrade | Outperform → Market Perform | $0 | 48% |
| Nov 13, 2025 | RBC Capital | downgrade | Outperform → Sector Perform | $8 | 55% |
| Nov 13, 2025 | Cantor Fitzgerald | downgrade | Overweight → Neutral | $0 | 50% |
| Nov 13, 2025 | Chardan Capital | downgrade | Buy → Neutral | $7 | 47% |
| Nov 13, 2025 | HC Wainwright & Co. | downgrade | Buy → Neutral | $0 | 44% |
| Oct 31, 2025 | Clear Street | initiate | — → Buy | $93 | 49% |
| Aug 13, 2025 | Chardan Capital | maintain | Buy → Buy | $25 | 47% |
| Aug 13, 2025 | Raymond James | maintain | Strong Buy → Strong Buy | $147 | 54% |
| Aug 13, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $90 | 44% |
| Jul 24, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| May 13, 2025 | Chardan Capital | maintain | Buy → Buy | $25 | 47% |
| May 13, 2025 | Oppenheimer | maintain | Outperform → Outperform | $90 | 52% |
| May 8, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $100 | 44% |
| Apr 29, 2025 | Cantor Fitzgerald | initiate | — → Overweight | $74 | 50% |
| Apr 16, 2025 | Chardan Capital | initiate | — → Buy | $25 | 47% |
| Mar 20, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $115 | 44% |
| Mar 19, 2025 | RBC Capital | maintain | Outperform → Outperform | $95 | 55% |
| Nov 22, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $115 | 44% |
| Nov 18, 2024 | Jones Trading | initiate | — → Buy | $130 | 50% |
| Nov 13, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $115 | 44% |
| Oct 21, 2024 | RBC Capital | maintain | Outperform → Outperform | $105 | 55% |
| Oct 21, 2024 | Raymond James | initiate | — → Strong Buy | $153 | 54% |
| Oct 18, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $115 | 44% |
| Sep 19, 2024 | RBC Capital | reiterate | Outperform → Outperform | $95 | 55% |
| Sep 17, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| Aug 14, 2024 | RBC Capital | maintain | Outperform → Outperform | $95 | 55% |
| Aug 14, 2024 | William Blair | initiate | — → Outperform | $0 | 48% |
| Aug 14, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| May 21, 2024 | HC Wainwright & Co. | reiterate | Buy → Buy | $100 | 44% |
| May 15, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $100 | 44% |
| May 15, 2024 | BMO Capital | maintain | Outperform → Outperform | $120 | 53% |
| Mar 28, 2024 | HC Wainwright & Co. | maintain | Buy → Buy | $115 | 44% |
| Mar 27, 2024 | Piper Sandler | maintain | Overweight → Overweight | $180 | 54% |
| Mar 27, 2024 | RBC Capital | maintain | Outperform → Outperform | $90 | 55% |
| Mar 26, 2024 | BMO Capital | reiterate | Outperform → Outperform | $120 | 53% |
| Mar 12, 2024 | RBC Capital | reiterate | Outperform → Outperform | $70 | 55% |
Price Target Trend
Apr 23, 2026 Latest: $20.2 Oct 25, 2026
EPS Estimates
0y $-5.23
Lo: $-7.25 Hi: $-4.22
10 analysts +1q $-1.36
Lo: $-2.44 Hi: $-0.74
10 analysts +1y $-4.42
Lo: $-5.04 Hi: $-3.55
8 analysts ▲4
0q $-1.26
Lo: $-2.04 Hi: $-0.93
10 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days